| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/30/2023 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 20k | $4.11 | $82.2k | | 06/30/2023 |
| 06/15/2022 | Nautilus Biotechnology, Inc. | | Grant | Stock Option (Right to Buy) | 86.5k | $2.70 | $233.5k | | 06/15/2022 |
| 07/15/2021 | ARYA Sciences Acquisition Corp V | | Grant | Class A ordinary shares | 499k | $10.00 | $5M | By ARYA Sciences Holdings V | 07/15/2021 |
| 06/09/2021 | Nautilus Biotechnology, Inc. | | Grant | | 44.4k | $11.16 | $495.9k | | 06/09/2021 |
| 06/09/2021 | Nautilus Biotechnology, Inc. | | Conversion | Class B ordinary shares | 3.6M | $0.00 | $0 | ARYA Sciences Holdings III | 06/09/2021 |
| 06/09/2021 | Nautilus Biotechnology, Inc. | | Conversion | Common Stock | 499k | $0.00 | $0 | ARYA Sciences Holdings III | 06/09/2021 |
| 06/09/2021 | Nautilus Biotechnology, Inc. | | Conversion | Common Stock | 3.6M | $0.00 | $0 | ARYA Sciences Holdings III | 06/09/2021 |
| 05/26/2021 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 7.2k | $7.24 | $52.5k | | 05/26/2021 |
| 03/02/2021 | ARYA Sciences Acquisition Corp IV | | Grant | Class A ordinary shares | 499k | $10.00 | $5M | By ARYA Sciences Holdings IV | 03/02/2021 |
| 08/11/2020 | Nautilus Biotechnology, Inc. | | Other (acquisition) | Class A ordinary shares | 499k | $10.00 | $5M | By ARYA Sciences Holdings III | 08/11/2020 |
| 06/09/2020 | Cerevel Therapeutics Holdings, Inc. | CERE | Other (acquisition) | Class A ordinary shares | 499k | $10.00 | $5M | By ARYA Sciences Holdings II | 06/09/2020 |
| 04/30/2020 | Lyra Therapeutics, Inc. | LYRA | Grant | Stock Option | 14.5k | $16.00 | $232k | | 04/30/2020 |